Ben is a Vice President at Prescient. He holds a BSc in Biomedical Sciences and an MSc in Biomedical Engineering, and prior to joining Prescient in 2010, he had eight years of professional experience in biotechnology. Ben has held progressively more senior roles at Prescient, which has given him a deep understanding of what is needed to build and motivate teams to deliver results with a high degree of client satisfaction. Ben is closely involved in managing projects across multiple therapeutic areas, including oncology, immunology and biosimilars.